Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
Crizotinib is superior to standard chemotherapy in patients with previously treated, advanced non-small-cell lung cancer with ALK rearrangement. (Funded by Pfizer; ClinicalTrial...